Skip to main content
. 2017 Mar-Apr;92(2):177–183. doi: 10.1590/abd1806-4841.20175140

Figure 2.

Figure 2

Immunological Analysis

A) Total IgE Mean [Percentile 25-75]; mild SCORAD 337IU [23-454]; Moderate 578IU [71-735]; Severe 872IU [872]. B) Specific IgE for Blo t (Mild 55 [52-62]; Moderate 59 [55-70]; Severe 60 [56-80]), Der p (Mild 96 [61-151]; Moderate 69 [56-143]; Severe 139 [84-163]) and Der f (Mild 86 [61-150]; Moderate 69 [56-143]; Severe 139 [86-151]). C) Specific IgG for Blo t (Mild 0,42 [0,40-0,76]; Moderate 0,43 [0,40-0,52]; Severe 0,45 [0,43-0,49]), Der p (Mild 0,50 [0,47-0,79]; Moderate 0,47 [0,44-0,52]; Severe 0,47 [0,44-0,62]) and Der f (Mild 0,52 [0,46-0,70]; Moderate 0,46 [0,44-0,64]; Severe 0,46 [0,43-0,69]). D) Specific IgG4 for Blo t (Mild 0,43 [0,41-0,43]; Moderate 0,44 [0,43-0,49]; Severe 0,46 [0,44-0,49]), Der p (Mild 0,46 [0,43-0,48]; Moderate 0,46 [0,43-0,53]; Severe 0,52 [0,46-0,54]) and Der f (Mild 0,45 [0,44-0,54]; Moderate 0,47 [0,43-0,52]; Severe 0,50 [0,46-0,53]).